Dealreporter
Bain’s take-private of Chindata set to face dissent from disgruntled minority shareholders
-
FTC challenge to Amgen’s $28B Horizon deal marks pharma's red-letter day – snap analysis
-
- 14 April is ACCC filing, not acceptance, deadline
- ACCC timeline could potentially last into 2024
-
- Unrealised losses could 'blow a hole' in bank balance sheets
- Regulatory tools from last financial crisis set to be tested
-
Small caps turn to debt, shelf offerings amid challenging capital markets – Roth Annual Conference
- Structured arrangements with lucrative terms seek to entice investors
- Lack of equity deals is forcing more companies to take on debt, warrants
- Investors exploring opportunities amid battered SPAC market
-
No more items to load
Load moreSomething went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports